Barclays PLC Baxter International Inc Transaction History

Barclays PLC

$327 Billion
Q2 2024

A detailed history of Barclays PLC transactions in Baxter International Inc stock. As of the latest transaction made, Barclays PLC holds 1,046,798 shares of BAX stock, worth $36.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,046,798

Previous 1,287,988 18.73%

Holding current value

$36.3 Million

Previous $55 Million 36.39%

% of portfolio

0.01%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$32.87 - $43.55 $7.93 Million - $10.5 Million	-241,190 Reduced 18.73%	1,046,798 $35 Million
Q1 2024 May 15, 2024	SELL	$37.88 - $43.77 $9.59 Million - $11.1 Million	-253,099 Reduced 16.42%	1,287,988 $55 Million
Q4 2023 Feb 15, 2024	SELL	$31.71 - $38.95 $13.5 Million - $16.6 Million	-426,110 Reduced 21.66%	1,541,087 $59.6 Million
Q3 2023 Nov 07, 2023	BUY	$37.32 - $49.29 $42 Million - $55.5 Million	1,125,101 Added 133.61%	1,967,197 $74.2 Million
Q2 2023 Aug 03, 2023	SELL	$39.98 - $47.68 $3.99 Million - $4.76 Million	-99,892 Reduced 10.6%	842,096 $38.4 Million
Q1 2023 May 04, 2023	SELL	$37.58 - $52.57 $4.45 Million - $6.22 Million	-118,299 Reduced 11.16%	941,988 $38.2 Million
Q4 2022 Feb 13, 2023	SELL	$49.7 - $57.71 $26,639 - $30,932	-536 Reduced 0.05%	1,060,287 $54 Million
Q3 2022 Nov 03, 2022	BUY	$53.86 - $66.8 $9.59 Million - $11.9 Million	177,974 Added 20.16%	1,060,823 $57.1 Million
Q2 2022 Aug 12, 2022	SELL	$63.83 - $80.0 $11.4 Million - $14.3 Million	-178,771 Reduced 16.84%	882,849 $56.7 Million
Q1 2022 May 16, 2022	BUY	$76.85 - $89.45 $8.22 Million - $9.56 Million	106,911 Added 11.2%	1,061,620 $82.3 Million
Q4 2021 Feb 14, 2022	BUY	$74.57 - $87.19 $13.7 Million - $16 Million	183,951 Added 23.87%	954,709 $82 Million
Q3 2021 Nov 09, 2021	BUY	$73.77 - $83.61 $1.06 Million - $1.2 Million	14,328 Added 1.89%	770,758 $62 Million
Q2 2021 Aug 13, 2021	BUY	$80.5 - $88.01 $22 Million - $24.1 Million	273,265 Added 56.56%	756,430 $60.9 Million
Q1 2021 May 13, 2021	BUY	$76.38 - $86.03 $4.17 Million - $4.7 Million	54,625 Added 12.75%	483,165 $40.7 Million
Q4 2020 Feb 11, 2021	SELL	$75.39 - $82.36 $119 Million - $130 Million	-1,573,312 Reduced 78.59%	428,540 $34.4 Million
Q3 2020 Nov 12, 2020	BUY	$78.33 - $90.73 $132 Million - $153 Million	1,682,861 Added 527.56%	2,001,852 $161 Million
Q2 2020 Aug 12, 2020	BUY	$78.66 - $94.14 $8.56 Million - $10.2 Million	108,785 Added 51.75%	318,991 $27.5 Million
Q1 2020 May 13, 2020	SELL	$71.57 - $93.3 $34.1 Million - $44.5 Million	-476,447 Reduced 69.39%	210,206 $17.1 Million
Q4 2019 Feb 10, 2020	SELL	$76.7 - $88.45 $10.7 Million - $12.3 Million	-139,164 Reduced 16.85%	686,653 $57.4 Million
Q3 2019 Nov 14, 2019	BUY	$81.4 - $89.78 $12.8 Million - $14.2 Million	157,712 Added 23.61%	825,817 $72.2 Million
Q2 2019 Aug 14, 2019	SELL	$73.44 - $82.41 $16.7 Million - $18.7 Million	-226,865 Reduced 25.35%	668,105 $54.7 Million
Q1 2019 May 15, 2019	SELL	$64.48 - $81.31 $22.6 Million - $28.4 Million	-349,784 Reduced 28.1%	894,970 $72.8 Million
Q4 2018 Feb 14, 2019	BUY	$61.45 - $77.8 $29.1 Million - $36.9 Million	473,690 Added 61.43%	1,244,754 $81.9 Million
Q3 2018 Nov 14, 2018	BUY	$70.71 - $77.75 $12.6 Million - $13.8 Million	178,129 Added 30.04%	771,064 $59.4 Million
Q2 2018 Aug 14, 2018	SELL	$63.43 - $75.41 $23.6 Million - $28 Million	-371,477 Reduced 38.52%	592,935 $43.8 Million
Q1 2018 May 15, 2018	SELL	$62.56 - $72.26 $8.79 Million - $10.2 Million	-140,491 Reduced 12.72%	964,412 $62.7 Million
Q4 2017 Feb 14, 2018	BUY	$61.45 - $66.05 $44.3 Million - $47.6 Million	720,143 Added 187.17%	1,104,903 $71.4 Million
Q3 2017 Nov 14, 2017	BUY	$59.5 - $64.61 $22.9 Million - $24.9 Million	384,760	384,760 $24.1 Million

Others Institutions Holding BAX

# of Institutions

998

Shares Held

450M

Call Options Held

1.97M

Put Options Held

3.04M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $17.5B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account